Philip Ashton-Rickardt - CHIEF SCIENTIFIC OFFICER at Sigilon Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
SGTX
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Philip Ashton-Rickardt since 12/22/2023

Holdings reported by Philip Ashton-Rickardt for Sigilon Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 0 $0.75 Aug 11, 2023 Direct Common Stock

Transactions reported by Philip Ashton-Rickardt for Sigilon Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.